Shelley Moore Capito bought Novartis AG ADR (NYSE: NVS)
Shelley Moore Capito (R-WV), a U.S. Senator, has disclosed 3 trades in Novartis AG ADR (NVS) since 2017, 2 purchases and 1 sale, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Shelley Moore Capito bought $1,001 - $15,000 of Novartis AG ADR (NYSE: NVS) on September 5, 2017. Since that trade, NVS is up +194.21% against the S&P 500 up +240.23%, an outperformance of -46.01%.
Across these filings, Shelley Moore Capito has been a net buyer of NVS (a buy-to-sell ratio of 2.00). The most recent disclosed NVS transaction shown was dated December 15, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Shelley Moore Capito's NVS trades vs the price
NVS is up +194.21% since Shelley Moore Capito bought on September 5, 2017, versus +240.23% for the S&P 500.
Performance since this trade
All Shelley Moore Capito NVS trades
Shelley Moore Capito & NVS trading FAQ
Is it legal for Shelley Moore Capito to trade Novartis AG ADR (NVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Shelley Moore Capito buy NVS?
Shelley Moore Capito disclosed a purchase of $1,001 - $15,000 of Novartis AG ADR (NVS) on September 5, 2017, according to public STOCK Act filings.
How has NVS performed since Shelley Moore Capito's trade?
Since Shelley Moore Capito bought NVS on September 5, 2017, the stock is up +194.21%, versus +240.23% for the S&P 500 over the same period, an outperformance of -46.01%.
How many times has Shelley Moore Capito traded NVS?
Shelley Moore Capito has disclosed 3 NVS trades since 2017 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVS trades?
Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.
Shelley Moore Capito's NVS tradesAll congressional filings for Novartis AG ADRShelley Moore Capito's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.